Related Experiment Video
Updated: Apr 25, 2026
Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans
Published on: October 5, 2020
DAF-16 target identification in C. elegans: past, present and future
1The Institute of Healthy Ageing, UCL, Gower St., London, WC1E 6BT, UK, J.M.A.Tullet@kent.ac.uk.
Abstract:
In C. elegans, mutations in the conserved insulin/IGF-1 signaling (IIS) pathway lead to a robust extension in lifespan, improved late life health, and protection from age-related disease. These effects are mediated by the FoxO transcription factor DAF-16 which lies downstream of the IIS kinase cascade. Identifying and functionally testing DAF-16 target genes has been a focal point of ageing research for the last 10 years. Here, I review the recent advances in identifying and understanding IIS/DAF-16 targets. These studies continue to reveal the intricate nature of the IIS/DAF-16 gene regulation network and are helping us to understand the mechanisms that control lifespan. Ageing and age related disease is an area of intense public interest, and the biochemical characterization of the genes involved will be critical for identifying drugs to improve the health of our ageing population.
Insights
Mutations in the insulin/IGF-1 signaling (IIS) pathway in C. elegans extend lifespan and improve health by activating the DAF-16 transcription factor. This review highlights recent advances in understanding IIS/DAF-16 targets and their role in aging.
Area of Science:
- Gerontology
- Molecular Biology
- Genetics
Background:
- The insulin/IGF-1 signaling (IIS) pathway is conserved across species and plays a crucial role in regulating lifespan and healthspan.
- In the nematode C. elegans, mutations in the IIS pathway robustly extend lifespan, enhance late-life health, and confer protection against age-related diseases.
- The FoxO transcription factor DAF-16 is a key downstream effector of the IIS pathway, mediating many of its beneficial effects.
Purpose of the Study:
- To review recent advancements in the identification and functional characterization of DAF-16 target genes.
- To elucidate the intricate gene regulatory network controlled by IIS and DAF-16.
- To deepen the understanding of the molecular mechanisms underlying lifespan regulation.
Main Methods:
- Literature review of recent studies on IIS/DAF-16 pathway.
- Analysis of gene expression data and functional assays for DAF-16 targets.
- Integration of findings to map the IIS/DAF-16 gene regulatory network.
Main Results:
- Recent studies have identified numerous DAF-16 target genes involved in diverse cellular processes.
- These targets reveal a complex regulatory network influencing metabolism, stress resistance, and proteostasis.
- Understanding these targets provides insights into how IIS modulates aging and age-related diseases.
Conclusions:
- The IIS/DAF-16 pathway is a central regulator of aging, with DAF-16 controlling a broad network of target genes.
- Continued biochemical characterization of these targets is essential for developing interventions to improve healthspan.
- This research holds promise for identifying novel therapeutic targets for age-related diseases in humans.
